Morgan Stanley Health Sciences Trust Inactive
Filed: 22 Nov 06, 12:00am
MORGAN STANLEY HEALTH SCIENCES TRUST 1221 Avenue of the Americas New York, NY 10020 November 22, 2006 Securities and Exchange Commission Judiciary Plaza 450 Fifth Street, N.W. Washington, D.C. 20549 Attention: Larry Greene, Division of Investment Management Mail Stop 0505 RE: MORGAN STANLEY HEALTH SCIENCES TRUST (FILE NOS. 33-48189 AND 811-6683) Dear Mr. Greene: Thank you for your telephonic comments regarding the registration statement on Form N-1A for Morgan Health Sciences Fund (the "Fund") filed with the Securities and Exchange Commission on September 27, 2006. Below, we describe the changes made to the registration statement in response to the Staff's comments and provide any responses to or any supplemental explanations of such comments, as requested. These changes will be reflected in post-effective amendment number 19 to the Fund's registration statement on Form N-1A, which will be filed via EDGAR on or about November 22, 2006. GENERAL COMMENTS TO FORM N-1A ----------------------------- COMMENT 1. PLEASE FILE A RESPONSE LETTER TO THESE COMMENTS VIA EDGAR, INCLUDING THE "TANDY" PROVISION. Response 1. This response letter addressing the Staff's comments has been filed via EDGAR correspondence, including the "Tandy" provision, separate from the corresponding Post-Effective Amendment. COMMENTS TO THE PROSPECTUS -------------------------- COMMENT 2. PLEASE NOTE THAT CERTAIN SIDEBARS IN THE PROSPECTUS APPEAR IN ALL CAPS IN THE EDGAR FILINGS WITH THE COMMISSION. PLEASE CONFIRM THAT THEY ARE NOT IN ALL CAPS AS THEY APPEAR IN THE PRINTED PROSPECTUS. Response 2. This disclosure appears in italics in the Fund's printed prospectus, not all caps. 1 COMMENT 3. CONSIDER ADDING DISCLOSURE REGARDING JUNK CONVERTIBLE SECURITIES, TO THE EXTENT THE FUND INVESTS IN THESE SECURITIES, TO THE "PRINCIPAL INVESTMENT STRATEGIES" SECTION. Response 3. Since the Fund may only invest up to 5% of its total net assets in junk convertible securities, we do not consider it a principal investment strategy of the Fund. Therefore, we believe the current risk disclosure in the SAI with respect to invesetments in junk convertible securities is sufficient. COMMENT 4. IN THE "FEES AND EXPENSES" SECTION OF THE PROSPECTUS, CONSIDER MOVING THE FOOTNOTES TO AFTER THE EXAMPLE. Response 4. We respectfully acknowledge the comment, but believe the current placement of the footnotes is appropriate. We believe to move the footnotes to below the Example would diminish the impact of the information and could result in a shareholder being unable to locate the footnotes. COMMENTS TO THE SAI ------------------- COMMENT 5. PLEASE ADD A DESCRIPTION OF THE FUND'S POLICIES WITH RESPECT TO BORROWING AND ISSUANCE OF SENIOR SECURITIES TO THE SAI. Response 5. The SAI currently includes such disclosure. Please see the section titled "Description of the Fund and Its Investments and Risks - Investment Strategies and Risks - Borrowing." As you have requested and consistent with SEC Release 2004-89, the Fund hereby acknowledges that: o the Fund is responsible for the adequacy and accuracy of the disclosure in the filings; o the Staff's comments or changes to disclosure in response to Staff comments in the filings reviewed by the Staff do not foreclose the Commission from taking any action with respect to the filings; and o the Fund may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. 2 If you would like to discuss any of these responses in further detail or if you have any questions, please feel free to contact me at (212) 762-6810. Thank you. Sincerely, /s/ Eric C. Griffith Eric C. Griffith